|

Nutrients in the News, hGH
August 1999--Ernest P.
Hawkins, M.S., R.Ph. NATURAL PHARMACY
Reprinted with permission from
Natural Pharmacy Magazine, and the author.
Human growth hormone (hGH) production is controlled by a complex
interplay of hypothalmic stimulatory and inhibitory peptides,
neurotransmitters, growth factors (GF), sex steroids, and nutritional
conditions. The most important regulators of HGH are the hypothalamic
factors-growth hormone-releasing factor (GRF), which is stimulatory; and
somatostatin, which is inhibitory. HGH increases the production of insulin-like
growth factor-1 (IGF-1, also known as somatomedin C), which in turn inhibits
hGH production, thus balancing its effects.1
Dramatic Decline
Production of HGH dramatically declines with age, and it is virtually
nonexistent at age 80. It also stimulates increased lean body mass, a
potentially life-extending function.2 Lean body mass has positive
effects on bone and organ density as well as proper organ function and
restoration of shrinking cells and body fluid balance. When it decreases in
adults, muscle weakness, organ failure, and possibly death may follow.
Signs of aging-such as skin wrinkling, osteoporosis, and organ
dysfunction-are directly related to the amount of HGH available.3
HGH and IGF-1 actually help DNA repair itself prior to cell division, with HGH
initiating the transport of amino acids and nucleic acids into the cell and
cell membrane. 
Treating GH Deficiency
Pharmaceutical use of recombinant human growth hormone (rHGH) is used
routinely for treating the symptoms of GH deficit in adults, even including
dwarfism. As the oral form of rHGH is not very absorbable, injectable rHGH is
used clinically in GH deficient individuals to decrease serum low-density
lipoprotein (LDL) cholesterol, 4 increase bone density, positively
affect body composition (decreasing bone mass while increasing lean body
mass),6 and improve exercise capacity and cardiac
function.5 On the down side, the large doses of rHGH used in the
clinical setting can produce a number of unwanted side effects-including fluid
retention, mild arthralgis, and hypertension.7 Using HGH as a
dietary supplement is illegal, but the U.S. Food and Drug Administration (FDA)
does recognize the use of homeopathic agents as over-the-counter (OTC) drugs.
Because they must follow strict FDA guidelines in their manufacturing
processes, they offer safety and freedom from side effects, making homeopathic
rHGH a highly beneficial and less invasive method of delivering HGH. Steven
Novil, Ph.D., director of the American Longevity Research Institute in Chicago,
Illinois, recently headed a double-blind controlled research study of
Regenesis' Regenesis Pro HGH product at the Waveland Wellness Center in
Chicago. The results of this study show test patients had significant gains.
Test patients showed an increase of 40% in IGF-1 levels compared to a 13%
increase in placebo patients; a 31.5% increase in DHEA compared to a 28%
decrease in placebo patients; and an 18.5% elevation of testosterone
levels.8
Homeopathic Use of rHGH
A novel and proprietary homeopathic preparation of rHGH has been
developed by Biomed Comm,® Inc. in Seattle, Washington, under
the direction of Barbara Brewitt, Ph.D., a leader in the use of rHGH as a
homeopathic dilution with proven clinical results. Homeopathic rHGH bypasses
problems of absorption by being absorbed sublingually.9 It is also
beneficial in managing fibromyalgia and hypopituitary disease, as well as an
adjunct in treating hypertension, obesity, hyperinsulinemia, and other
conditions. Other studies report that it has a host of other benefits-including
increasing energy and muscle mass without exercise; decreasing body fat without
dieting; and improving immune system function, sleep patterns, respiratory
function, and vision.9
Ernest P. Hawkins, M.S., R.Ph., works in pharmacy as well as the
biotechnological research and herbal industries.
Selected References 1. Ho KK. Metabolic actions of growth
hormone in man. Endocr J 43(suppl):S57-S63, 1996. 2. Corpas E, et al. Human
growth hormone and human aging. Endocr Rev 14:20-39, 1993. 3. Salomon F, et
al. The effects of treatment with recombinant human growth hormone on body
composition and metabolism in adults with growth hormone deficiency. N Engl J
Med 321:1797-1803, 1989. 4. Huillard d'Aignaux J, et al. A statistical
model to identify the contaminated lots implicated in iatrogenic transmission
of Creutzfeldt-Jakob disease among French human growth hormone recepients. Am J
Epidemiol 147:597-604, 1998. 5. al-Shoumer KA, et al. Effects of four
years' treatment with biosynthetic human growth hormone (GH) on glucose
homeostasis, insulin secretion, and lipid metabolism in GH-deficient adults.
Clin Endocrinol (Oxf) 48:795-802, 1998. 6. Amato G, et al. Low dose
recombinant human growth hormone normalizes bone metabolism and cortical bone
density and improves trabecular bone density in growth hormone deficient adults
without causing adverse effects. Clin Endocrinol (Oxf) 451:27-32, 1996. 7.
Bengtsson BA, et al. Treatment of adults with growth hormone (GH) deficiency
with recombinant human GH. J Clin Endocrinol Metab 76:309-317, 1993. 8.
Regenesis information, June 17, 1999. 9. Barbara Brewitt, Ph.D., personal
communication, May 30, 1999. |